Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Radiofrequency versus microwave ablation for non-functioning benign thyroid nodules: a single-institution comparative cohort study.

Created on 11 Oct 2026

Authors

A Thornton, I Comens, E J Kuo, J A Lee, C McManus, J H Kuo

Published in

Endocrine. Volume 91. Issue 1. Oct 10, 2026. Epub Oct 10, 2026.

Abstract

Thermal ablation (TA) has emerged as an alternative to surgery in selected patients with benign thyroid nodules, achieving substantial nodule volume reduction with improved cosmesis and lower risk of post-procedural hypothyroidism than thyroidectomy. However, comparative data from North American practice remain limited. We compared the efficacy and safety of radiofrequency ablation (RFA) and microwave ablation (MWA) for non-functioning benign thyroid nodules.
In this single-institution comparative cohort, 224 patients with 291 nodules underwent RFA and 47 patients with 60 nodules underwent MWA for non-functioning benign thyroid nodules (2019-2025). Nodule volume, volume reduction ratio (VRR), symptoms, cosmesis, and complications were compared between the modalities over a 12-month follow-up period.
Baseline volumes were larger in the MWA cohort (median 29.0 vs. 16.6 mL, p = 0.004). Median VRR reached 77.8% (RFA) and 70.8% (MWA) by 12 months, with no significant between-group difference at any timepoint. After adjustment for baseline volume, estimated mean volume did not differ significantly between modalities. Final nodule volume tracked closely with baseline volume across volume groups. Median symptom and cosmesis scores improved for each group post-ablation. Complication rates were low and similar between groups, the most common being periprocedural pain (15.6% RFA, 12.8% MWA).
RFA and MWA achieved comparable volume reduction, symptom improvement, and complication rates for non-functioning benign thyroid nodules.

PMID:
42859321
Bibliographic data and abstract were imported from PubMed on 11 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement